MedTrace Logo

Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women

NCT03196492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2021-06-18

No results posted yet for this study

Summary

The investigators are doing a study on the bacteria that normally live in the vagina and what effect, if any, Depo-Provera has on the bacteria.

Women 13-24 years of age, who are HIV negative, being seen in a clinic for birth control or sexually transmitted disease (STD) check-up, or have a child and are planning to receive a Depo-Provera shot for contraception or have declined the use of hormonal contraception may join.

Conditions

  • Microbial Colonization

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Maryland, College Park

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Jenell Coleman Fennell, MD · Johns Hopkins University

Eligibility

Min Age
13 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2021-06-14
Completion
2021-06-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03196492 on ClinicalTrials.gov